1. Demand is steady, led by body and breast operations
The latest full-year US figures are a useful baseline. They describe the operations most often marketed abroad. The American Society of Plastic Surgeons reported nearly 1.6 million cosmetic surgical procedures in 2024, up 1% from the year before, and more than 28.5 million minimally invasive procedures (ASPS, 2025).
Breast lift (153,616) and eyelid surgery (120,755) completed the top five. Neuromodulator injections led the minimally invasive list at almost 9.9 million. The CDC Yellow Book (2026) lists the cosmetic procedures commonly sought abroad as abdominoplasty, breast augmentation, buttock augmentation, liposuction and rhinoplasty. These are largely the same operations, which means destination clinics are competing for patients who could easily be treated at home. That puts the burden on the trip to justify itself.
2. GLP-1 patients are a new planning category
For the first time, the ASPS 2024 report measured weight-loss medication use among its members' patients. More than 800,000 aesthetic patients used these drugs in 2024. Among GLP-1 patients under ASPS member care, 20% had already had plastic surgery, 39% were considering a surgical procedure and 41% were considering a nonsurgical one. ASPS also stressed that body contouring is not a substitute for weight-loss surgery.
This matters for travel in two ways. First, anesthesia: in October 2024, the American Society of Anesthesiologists and four other societies said most patients can keep taking GLP-1 drugs before elective surgery (ASA, 2024). The same guidance says elective surgery should wait for patients still in the dose-escalation phase or with active stomach symptoms. It also calls for a liquid-only diet for 24 hours beforehand in patients at the highest risk of stomach side effects. Patients should tell their anesthesiologist, surgeon and prescriber about GLP-1 use. That's harder when those three are in different countries and only meet you days before surgery.
Second, timing: contouring after major weight loss is often planned around a stable weight and can involve more than one operation. Our guide to body lifts after weight loss abroad covers staging. In 2026, a clinic that never asks about your weight-loss medication is a clinic to question.
3. BBL technique standards have hardened
Gluteal fat grafting is where technique rules changed most. An ASPS task force formed in 2018 concluded that fat should only be placed in the subcutaneous space, above the muscle (ASPS, 2023). Florida's Board of Medicine ruled in 2019 that doctors who injected fat into muscle could lose their license. A 2022 emergency order there required ultrasound during BBL surgery and limited surgeons to three BBLs a day, citing surgeon fatigue. The 2023 article quotes a task-force surgeon citing survey data that mortality is now about one in 15,000, roughly that of a tummy tuck.
Those are US rules, and other countries' rules differ. They still give you a concrete benchmark. Ask any clinic abroad which plane the fat goes into, whether ultrasound is used, and how many of these operations the surgeon does in a day. Our comparison of BBL destinations covers country-level factors.
4. Breast implant paperwork got stricter in the US
In October 2021, the FDA approved new labeling for breast implants marketed in the United States: a boxed warning, a patient decision checklist and a patient device card (FDA, 2023). Patients treated at home increasingly expect that documentation. Patients treated abroad may not get it unless they ask. Our article on keeping the device and operative record explains what to collect.
5. Home countries now look for resistant infections
The 2026 Yellow Book says the risk of antimicrobial-resistant infections may be higher in some countries, and that organisms like CRE and Candida auris are seen more often in certain destinations. It recommends that anyone from the US who spent a night in a healthcare facility abroad in the last six months be screened for CRE. That screening is free through CDC's Antibiotic Resistance Laboratory Network. CDC also asks to be notified of medical-tourism complications. For travelers, this means a home hospital may screen or isolate you after surgery abroad, so tell them where you were treated.
6. More honest evidence, still no denominators
Research on returning patients is getting more organized, but it still counts only those who come home with problems. Our explainer on what the safety data can and can't show goes through the main 2022 systematic review and its limits.
What the trends mean for planning a trip this year
Taken together, these shifts move work earlier in the planning process. A few years ago, much of the vetting for a cosmetic trip happened at the in-person consultation. In 2026, several of the deciding questions need answers before you book:
- Medication history goes in the first message. If you take a GLP-1 drug, the anesthesia plan may depend on where you are in your dosing, and that affects the surgery date and so the flights.
- Technique questions go in writing. For gluteal fat grafting especially, ask how the clinic answers the technique questions above before you compare prices. A vague answer is useful information.
- Paperwork expectations get set early. Ask about implant documentation and operative reports when you request a quote, not at discharge.
- The home side of the trip is part of the plan. Expect your home clinicians to ask where you were treated, and possibly to screen you. Have your records ready so that conversation is quick.
None of these steps needs special access. All of them reward patients who ask early and in writing.
Nonsurgical treatments: high volume, different maths
The biggest numbers in the ASPS report are for injectables, not surgery. Neuromodulator injections alone were close to 9.9 million in 2024, and hyaluronic acid fillers were over 5.3 million. These treatments are widely offered at home. If the one you want is meant to be repeated over time, ask your provider. If it is, travelling for it means comparing one trip abroad with a series of local appointments. The travel case is then usually much weaker than for surgery, unless the treatment fits into a trip you are already making.
What isn't a trend
Discount claims you can't trace to a source. We found no official body publishing a reliable 2026 count of people traveling abroad for cosmetic surgery. Treat "record numbers" headlines and destination "rankings" with care. A new device or technique name in a clinic advert isn't a trend either until you can find independent evidence for it. The same goes for package names. Words like "all-inclusive", "VIP" or "premium recovery" describe marketing, not a change in care. What counts is what the package actually contains, in writing.
| Trend | Question to send the clinic |
|---|---|
| GLP-1 use | How will the anesthesia team handle my medication and the hours before surgery? |
| BBL technique | Where is the fat placed, is ultrasound used, and how many cases does the surgeon do per day? |
| Implant paperwork | Will I leave with the device documentation and a signed risk checklist? |
| Resistant infections | What is your infection-control protocol, and how will you share culture results if I develop an infection? |
The Takeaway
The useful 2026 trends are about patients, techniques, paperwork and screening, not destinations. Turn each into a written question before you book, and expect specific answers.
Frequently asked questions
Are more people having cosmetic surgery in 2026?
The latest full-year ASPS data, for 2024, shows US demand roughly steady: nearly 1.6 million cosmetic surgical procedures, up 1% from the prior year. We found no reliable official count of how many people travel abroad for it.
Can I have cosmetic surgery abroad while taking a GLP-1 drug?
That's a decision for your anesthesia and surgical team. The 2024 multi-society guidance says most patients can continue GLP-1s before elective surgery. It says surgery should wait during dose escalation or active stomach symptoms. Tell everyone involved that you take one.
Is ultrasound-guided BBL required everywhere?
No. Florida required ultrasound during BBL surgery through a 2022 emergency order, but rules differ between places. Ask any clinic directly whether it uses ultrasound and where it places the fat.
Will my hospital at home treat me differently after surgery abroad?
It may screen you. The CDC recommends CRE screening for US patients who spent a night in a healthcare facility abroad in the last six months.
Are destination rankings a reliable trend signal?
Usually not. Rankings rarely say how they were built, and no official source we found tracks outcomes for cosmetic travelers by country.
Sources cited: ASPS 2024 statistics press release (2025); CDC Yellow Book 2026: Medical Tourism; ASA: Multi-society GLP-1 guidance (2024); ASPS: Improving Safety for the BBL (2023); FDA: Things to Consider Before Getting Breast Implants (2023). Educational content only, not medical advice.